CYCLERION THERAPEUTICS INC's ticker is CYCN and the CUSIP is 23255M105. A total of 36 filers reported holding CYCLERION THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $38 | -68.3% | 86,700 | -52.8% | 0.00% | – |
Q4 2022 | $120 | -100.0% | 183,580 | -35.2% | 0.00% | – |
Q3 2022 | $244,000 | -2.4% | 283,388 | -37.9% | 0.00% | – |
Q2 2022 | $250,000 | -25.6% | 456,077 | +50.7% | 0.00% | – |
Q1 2022 | $336,000 | -43.5% | 302,558 | -12.5% | 0.00% | -100.0% |
Q4 2021 | $595,000 | +168.0% | 345,900 | +378.4% | 0.00% | – |
Q3 2021 | $222,000 | -80.0% | 72,300 | -74.6% | 0.00% | -100.0% |
Q2 2021 | $1,111,000 | +70.7% | 284,744 | +22.1% | 0.00% | 0.0% |
Q1 2021 | $651,000 | +1083.6% | 233,200 | +1202.8% | 0.00% | – |
Q4 2020 | $55,000 | -89.0% | 17,900 | -78.9% | 0.00% | – |
Q2 2020 | $502,000 | +239.2% | 85,000 | +52.3% | 0.00% | – |
Q1 2020 | $148,000 | – | 55,801 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Slate Path Capital LP | 7,157,601 | $3,105,683 | 0.15% |
Artal Group S.A. | 2,779,122 | $1,206 | 0.07% |
MFN Partners Management, LP | 3,389,215 | $1,470,580 | 0.07% |
Intrinsic Value Partners, LLC | 43,105 | $18,703 | 0.02% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 115,000 | $49,899 | 0.00% |
Penobscot Investment Management Company, Inc. | 10,000 | $4,339 | 0.00% |
COLONY GROUP LLC | 102,884 | $44 | 0.00% |
CAPTRUST FINANCIAL ADVISORS | 292,645 | $126,979 | 0.00% |
GEODE CAPITAL MANAGEMENT, LLC | 592,237 | $256,971 | 0.00% |
STATE STREET CORP | 115,414 | $50,078 | 0.00% |